科懋生物科技股份有限公司
該股 RSI(6) 為 61.2，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、20日均線，跌破60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=75.2）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
科懋生物科技股份有限公司（Excelsior Biopharma Inc.）在台灣及中國開發銷售醫藥產品。提供學名藥、罕見疾病藥物（孤兒藥）、解毒劑、快篩試劑及特殊醫學營養品。涉及原料藥進出口與醫藥技術轉讓。公司成立於 1986 年，總部位於台灣台北。
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 10-30 | -1 | 0 | 0 | -1 |
| 10-27 | -1 | 0 | 0 | -1 |
| 10-20 | -1 | 0 | 0 | -1 |
| 10-19 | -12 | 0 | 0 | -12 |
| 10-16 | +1 | 0 | 0 | +1 |
| 10-13 | -2 | 0 | 0 | -2 |
| 10-12 | -4 | 0 | 0 | -4 |
| 10-08 | -1 | 0 | 0 | -1 |
| 10-07 | +5 | 0 | 0 | +5 |
| 10-05 | -2 | 0 | 0 | -2 |
| 10-02 | +1 | 0 | 0 | +1 |
| 10-01 | +1 | 0 | 0 | +1 |
| 09-30 | +10 | 0 | 0 | +10 |
| 09-21 | +3 | 0 | 0 | +3 |
| 09-18 | +3 | 0 | 0 | +3 |
| 08-21 | 0 | 0 | 0 | 0 |
| 08-18 | -1 | 0 | 0 | -1 |
| 08-14 | +1 | 0 | 0 | +1 |
| 08-12 | -1 | 0 | 0 | -1 |
| 08-10 | +1 | 0 | 0 | +1 |
| 08-05 | +1 | 0 | 0 | +1 |
| 07-29 | -7 | 0 | 0 | -7 |
| 07-28 | -2 | 0 | 0 | -2 |
| 07-22 | -1 | 0 | 0 | -1 |
| 07-17 | +2 | 0 | 0 | +2 |
| 07-14 | 0 | 0 | 0 | 0 |
| 07-09 | -2 | 0 | 0 | -2 |
| 07-08 | -1 | 0 | 0 | -1 |
| 07-07 | 0 | 0 | 0 | 0 |
| 07-06 | +1 | 0 | 0 | +1 |
| 07-03 | +2 | 0 | 0 | +2 |
| 07-01 | -2 | 0 | 0 | -2 |
| 06-30 | -2 | 0 | 0 | -2 |
| 06-26 | -1 | 0 | 0 | -1 |
| 06-25 | -2 | 0 | 0 | -2 |
| 06-24 | 0 | 0 | 0 | 0 |
| 06-23 | +2 | 0 | 0 | +2 |
| 06-17 | -1 | 0 | 0 | -1 |
| 06-16 | -3 | 0 | 0 | -3 |
| 06-12 | -1 | 0 | 0 | -1 |
| 06-10 | -1 | 0 | 0 | -1 |
| 06-09 | +3 | 0 | 0 | +3 |
| 06-08 | +3 | 0 | 0 | +3 |
| 06-05 | 0 | 0 | 0 | 0 |
| 06-04 | +2 | 0 | 0 | +2 |
| 06-03 | 0 | 0 | 0 | 0 |
| 06-02 | -5 | 0 | 0 | -5 |
| 06-01 | +2 | 0 | 0 | +2 |
| 05-29 | -3 | 0 | 0 | -3 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/10 | 9476 萬 | +24.1% | +32.5% |
| 2026/09 | 7637 萬 | +16.1% | +7.3% |
| 2026/08 | 6577 萬 | -25.2% | -4.0% |
| 2026/07 | 8797 萬 | +26.8% | +30.4% |
| 2026/06 | 6940 萬 | -10.7% | +10.1% |
| 2026/05 | 7775 萬 | -8.9% | +6.9% |
| 2026/04 | 8533 萬 | +29.3% | +28.9% |
| 2026/03 | 6600 萬 | +16.9% | -16.2% |
| 2026/02 | 5644 萬 | -41.0% | -6.6% |
| 2026/01 | 9561 萬 | -23.9% | +35.1% |
| 2025/12 | 1.26 億 | +52.9% | +34.2% |
| 2025/11 | 8214 萬 | - | +12.3% |